Ibogaine By David Dardashti Announces Opening Of Second Clinic With Expanded, Holistic Care Model

SWEETWATER, FL - Sep 22, 2025 - Ibogaine by David Dardashti, a leading provider of ibogaine-assisted therapy, is pleased to announce the opening of its second, state-of-the-art facility. This expansion represents a significant evolution in the clinic's treatment philosophy, broadening its focus beyond traditional addiction recovery to provide a more holistic approach to health and wellness.
The new clinic will offer tailored treatment protocols to address a range of patient needs, from substance use disorders to non-addiction-related issues such as trauma and depression. The existing facility will now be exclusively dedicated to the complex challenges of addiction, including the treatment of highly potent substances like fentanyl.
Innovations in Patient and Family Support
In a groundbreaking new initiative, the clinic will now allow patients the option of bringing a family member to help offer support during treatment. This unique addition to the care model recognizes the crucial role a strong support system plays in the healing journey. By involving a loved one, the clinic aims to foster a more connected and sustainable path to recovery.
Enhanced Medical and Therapeutic Staff
To support this expanded mission, the clinic has significantly increased its team of medical professionals. The addition of dedicated medical staff at both facilities is a necessary step to ensure that all patients receive the highest level of care. This commitment to a medically supervised environment is paramount, especially given the psychoactive nature of ibogaine and the need for careful patient screening and monitoring.
About Ibogaine by David Dardashti
Founded 21 years ago, Ibogaine by David Dardashti has been a pioneer in the field of ibogaine therapy, providing safe, medically supervised treatment for thousands of individuals. The organization is committed to ethical practice, patient safety, and advancing the understanding of ibogaine's therapeutic potential for a wide range of conditions.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Kucoin Partners With Golf Icon Adam Scott As Global Brand Ambassador
- Mediafuse Joins Google For Startups Cloud Program To Scale AI-Driven, Industry-Focused PR Distribution
- Solotto Launches As Solana's First-Ever Community-Powered On-Chain Lottery
- 1Inch Unlocks Access To Tokenized Rwas Via Swap API
- Leverage Shares Launches First 3X Single-Stock Etps On HOOD, HIMS, UNH And Others
- Forex Expo Dubai 2025 Returns October 67 With Exclusive Prize Draw Including Jetour X70 FL
Comments
No comment